Wigzell Hans Lennart Rudolf
SEC CIK 1492766 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | Dir | 42.1K | — | $4.76M | 11 | 2022-03-07 | 2026-06-04 |
Most active insiders at SRPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Estepan Ian Michael | COO | — | $294.2K |
| 2 | Mayo Stephen | Dir | — | $123.2K |
| 3 | Wong Ryan Ho-Yan | CFO | — | — |
| 4 | Rothfuss Cristin | EVP, GC | — | — |
| 5 | Chambers Michael Andrew | Dir | — | — |
| 6 | Rodino-Klapac Louise | Pres, R, D, Tech Ops | — | — |
| 7 | Boor Kathryn Jean | Dir | — | — |
| 8 | Nicaise Claude | Dir | — | — |
| 9 | SEVERINO MICHAEL | CEO, Dir | — | — |
| 10 | Barry Richard | Dir | — | — |
| 11 | Wigzell Hans Lennart Rudolf | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 20:09 | 2026-06-04 | SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Dir | A - Grant | — | +16.9K | 42.1K | +67% | — | |
| D | 2025-03-11 | 2025-03-10 | SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Dir | A - Grant | — | +2,383 | 25.2K | +10% | — |
| D | 2024-12-16 | 2024-12-12 | SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Dir | S - Sale+OE | $124.84 | -10.5K | 22.8K | -31% | -$1.31M |
| D | 2024-12-16 | 2024-12-12 | SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Dir | M - OptEx | $13.71 | +10.5K | 33.3K | +46% | +$144.0K |
| D | 2024-03-11 | 2024-03-08 | SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Dir | M - OptEx | $13.90 | +15.0K | 37.8K | +66% | +$208.5K |
| DM | 2024-03-11 | 2024-03-08 | SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Dir | S - Sale+OE | $123.25 | -15.0K | 34.7K | -30% | -$1.85M |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Dir | A - Grant | $0.00 | +1,846 | 22.8K | +9% | $0 |
| D | 2023-08-08 | 2023-08-04 | SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Dir | M - OptEx | $29.03 | +15.0K | 36.0K | +71% | +$435.4K |
| D | 2023-08-08 | 2023-08-04 | SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Dir | S - Sale+OE | $106.72 | -15.0K | 21.0K | -42% | -$1.60M |
| D | 2023-03-08 | 2023-03-06 | SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Dir | A - Grant | $0.00 | +1,523 | 21.0K | +8% | $0 |
| D | 2022-03-08 | 2022-03-07 | SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Dir | A - Grant | $0.00 | +2,953 | 19.5K | +18% | $0 |
Purchase Sale Sale after option exercise All abbreviations